The Department of Health (DOH) assured on Thursday, June 22, that the current and the incoming antiretroviral stocks will be enough to cover the HIV treatment facilities until April 2024. *Unsplash* DOH made the remark in response to the statement released by Network Plus Philippines, Inc. requesting the agency to address the observed unstable supply of antiretroviral drugs in HIV facilities. "DOH remains committed to ensure the safety and well-being of all people living with HIV (PLHIV) in the country," it said. In a statement, DOH clarified that the reported incidents of low stocks of antiretroviral drugs, particularly Tenofovir-Lamivudine-Dolutegravir (TLD), could be attributed to the unprecedented increase in the use of TLD among PLHIV prior to the targeted full-scale rollout of the transition from their existing regimens. The health agency added that in accordance with the Philippine TLD Transition Plan, treatment-naive patients, as well as those who developed adverse drug reactions in their current regimens (i.e., efavirenz), were prioritized for transition to TLD from 2020 to 2022. "However, as the PLHIV community became more aware of the promising superiority of TLD over other regimens through word of mouth, social media, learning sessions with support groups, and information dissemination by the treatment facilities, there was notable increase in the uptake of TLD across the facilities," it said. DOH mentioned that the initial tranche (58,000 bottles) of the FY 2023 DOH-procured TLD is expected to arrive in the country by the end of June and is expected to cover all current patients, estimated new enrollees, and estimated shiftees based on the updated TLD transition plan until the rest of the tranches (Tranche 2: 243,000 bottles by July 2023 and Tranche 3: 292,000 bottles by September 2023) are delivered. DOH also stated that a reorder of 25 percent of the total procurement (146,000 bottles) will be facilitated to ensure adequate supply until next year. Additionally, the agency will facilitate early procurement for FY 2024 to make sure that there will be no gap in the supplies in the facilities. "Rest assured that the Department is taking necessary measures to ensure adequate supplies of TLD for our PLHIV Community," it said.